Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00374426
Status:
COMPLETED
Last Update Posted:
2010-03-02
First Post:
2006-09-08
Brief Title:
Preventing Depression Recurrence in Diabetes
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
Preventing Depression Recurrence in Diabetes
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the effectiveness of sertraline Zoloft in treating depression in adults with diabetes The study will also determine whether depressed diabetic patients who have successfully responded to sertraline Zoloft are more likely to have depression recur if the sertraline Zoloft is discontinued
Detailed Description:
Part A Prevention of Depression Recurrence in Diabetes
1 To determine the efficacy of maintenance antidepressant medication in preventing or delaying recur-rence of major depression in diabetes
2 To determine the relationship of sustained depression remission to social occupational and global func-tioning and to quality of life and compliance with diabetes treatment
3 To determine clinical features predictive of depression recurrence in diabetes
Part B Longitudinal Study of the Interrelationship of Glycemic Control and Depression
1 To determine the effects of depression remission and recurrence on glycemic control
2 To determine the efficacy of maintenance antidepressant medication in producing sustained benefits in glycemic control
3 To determine the interrelationship of daily mood with blood glucose and the effect of maintenance treatment on this relationship
1 To determine the efficacy of maintenance antidepressant medication in preventing or delaying recur-rence of major depression in diabetes
2 To determine the relationship of sustained depression remission to social occupational and global func-tioning and to quality of life and compliance with diabetes treatment
3 To determine clinical features predictive of depression recurrence in diabetes
Part B Longitudinal Study of the Interrelationship of Glycemic Control and Depression
1 To determine the effects of depression remission and recurrence on glycemic control
2 To determine the efficacy of maintenance antidepressant medication in producing sustained benefits in glycemic control
3 To determine the interrelationship of daily mood with blood glucose and the effect of maintenance treatment on this relationship
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DK53060 | None | None | None |